Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$15.83 -0.12 (-0.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) Cash & Current Investments (2016 - 2026)

Updated

Aurinia Pharmaceuticals' Cash & Current Investments came in at $443.12 million for Q2 2026, up 40.6% from $315.13 million a year earlier and up 17.0% from the prior quarter.

Analysis

Aurinia Pharmaceuticals (AUPH) Cash & Current Investments (2016 - 2026) Analysis & Trends

At the end of FY2025, Aurinia Pharmaceuticals' Cash & Current Investments was $398 million, up 11.0% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $358.48 million in FY2024 (+2.3%), $350.49 million in FY2023 (-10.0%), $389.39 million in FY2022 (-16.5%) and $466.08 million in FY2021 (+17.0%).
  • The Q2 2026 figure represents the highest quarterly Cash & Current Investments since Q4 2021.
  • Year-over-year, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 9.0% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2026 (growth of 40.6%), and the weakest in Q4 2022 (a decline of 16.5%).
  • Business Quant data shows AUPH's Cash & Current Investments at $378.78 million (Q1 2026), $398 million (Q4 2025) and $351.81 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Aurinia Pharmaceuticals 2.10 Bn 532.21 Mn 76.67 Mn 443.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 443.12 Mn
Mar 31, 2026 378.78 Mn
Dec 31, 2025 398.00 Mn
Sep 30, 2025 351.81 Mn
Jun 30, 2025 315.13 Mn
Mar 31, 2025 312.90 Mn
Dec 31, 2024 358.48 Mn
Sep 30, 2024 348.75 Mn
Jun 30, 2024 330.48 Mn
Mar 31, 2024 319.91 Mn
Dec 31, 2023 350.49 Mn
Sep 30, 2023 337.90 Mn
Jun 30, 2023 350.71 Mn
Mar 31, 2023 361.53 Mn
Dec 31, 2022 389.39 Mn
Sep 30, 2022 376.64 Mn
Jun 30, 2022 391.74 Mn
Mar 31, 2022 418.75 Mn
Dec 31, 2021 466.08 Mn
Sep 30, 2021 286.40 Mn
API Access

Aurinia Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AUPH&period=max&api_key=YOUR_API_KEY